New study tests whooping cough vaccine in pregnant women with HIV

NCT ID NCT05264662

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well the whooping cough (pertussis) vaccine works in pregnant women with and without HIV, and whether it is safe for them and their babies. Over 500 pregnant women received the vaccine during their second or third trimester. Researchers measured antibody levels in the mothers and their infants to see if the vaccine provides protection against whooping cough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DTAP VACCINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chris Hani Baragwanath Academic Hospital

    Johannesburg, GP, 2192, South Africa